Filings: Pfizer settles lawsuit involving Celebrex - Yahoo Finance

SALT LAKE CITY (AP) -- Pfizer Inc. has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for $450 million, according to a regulatory filing Tuesday. Terms of the settlement weren't ...

Pfizer settles lawsuit from BYU over Celebrex case - Yahoo Finance

SALT LAKE CITY (AP) -- Pfizer Inc. has announced the settlement of a multi-billion-dollar lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex. Terms of the settlement weren't disclosed by the drug ...

For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed Thought Leaders Indicate That Tanezumab Has Advantages Over Celebrex - Business Wire

Duexis Will Earn a Patient Share of Less Than 5 Percent in the U.S. Osteoarthritic Pain Market by 2020, According to Findings from Decision Resources BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory ...

Business Digest, May 1: California adds 250,000 more people - San Gabriel Valley Tribune

Pfizer settles Celebrex lawsuit Pfizer Inc. has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for $450 million. BYU and Pfizer battled for six years over the discovery of an enzyme ...

Q&A with Garret FitzGerald, Univ. of Pennsylvania expert on drugs and heart risks - Philadelphia Daily News

What did you find? A: Before any of these drugs were on the market, we had a chance to examine how Vioxx and Celebrex (celecoxib) acted in humans. To our surprise, we found that both drugs suppressed prostacyclin, as reflected by a breakdown ...

Drug Ads Often Gloss Over Side Effects, Enlist Doctor Endorsements - 24-7PressRelease.com

Other drug advertisements, like those for Celebrex, place a lot of emphasis on the benefits of the drug while downplaying serious side effects like heart attack or stroke. Another common technique is enlisting the endorsement of an actual physician ...

MCC reports 80 percent annual growth over five years - Cincinnati.com

Geis is famous in pharmaceutical circles as the man behind Celebrex. He was the global vice president for arthritis, pain and oncology at Pharmacia when Kleeman was a young medical writer. Celebrex was the first selective COX-2 inhibitor approved by FDA.

How pain medication Vioxx ups heart disease risk - in.news.yahoo.com

Since then, other drugs in the class from Pfizer, Novartis, and Merck have been withdrawn (Bextra); have failed to be approved (Arcoxia, Prexige); or have been retained on the market in the US with a "black box" warning on the label (Celebrex). COX-2 is ...

RA & Heart Disease: Maintaining A Healthy Heart - HealthCentral.com

RA medications that are thought to increase our chances of developing heart disease include Prednisone, and other steroids, non-steroidal anti-inflammatory drugs (NSAIDs), and Celebrex. I take 400 mg of Celebrex every day, even though I have high blood pressure.

Humira Could Have Been a Pfizer Drug - Forbes

But Pfizer felt there were a few problems to overcome. Pfizer had just entered into a co-promotion deal with Pharmacia (then G.D. Searle) in 1998 to sell Celebrex, the anti-inflammatory COX-2 inhibitor. Furthermore, Pharmacia had a second ...